Public health officials warn that the Trump administration’s proposed cuts of up to $140 million to the Centers for Disease Control and Prevention (CDC) could significantly undermine national efforts to prevent fatal drug‑related harm. The funding at risk supports the CDC’s Overdose Data to Action (OD2A) program, launched in 2019, which enables state and local health departments to track substance use trends, monitor changes in the drug supply, and implement prevention strategies such as naloxone distribution. The program was expanded in 2023 under the Biden administration through five‑year grants to 90 jurisdictions. However, the program faces uncertainty as funds could expire at the end of the first two‑year cycle on September 1, potentially disrupting harm-prevention efforts nationwide.
Learn more.